© 2019 The Sonder Group

Well, we are little more than half-way through 2013 and I couldn’t resist giving my business impressions on the year so far, and think about how that affects business growth and hiring. If you pardon the sports analogies, get your head in the game, and let’s figure out the game plan.

The scoreboard: Stocks & IPOs –  Earlier this month, Burrill and company reported good news. Life science stocks were out performing other major indices this year. Life Science companies raised $56.2 billion in cash during the first half of 2013; 60% more...

Looking for something to do with the family this summer?  Washington DC is always a good idea with so many enlightening family-oriented exhibits to see. But for all of you science geeks, it just got better with the opening of a new exhibit at the Smithsonian Museum – Genome: Unlocking Life’s Code. It  celebrates the 10th anniversary of the original draft sequence of the human genome and I had the pleasure of touring the exhibit on opening day, Friday June 14. It’s right upstairs on the 2nd floor of the Smithsonian’s Natural History Mu...

Rally for Medical Research
Monday, April 8, 2013, 11:00 a.m.
Carnegie Library Grounds at Mt. Vernon Square
801 K Street, NW, Washington, DC 20001

In 1897, a one-room diagnostic laboratory was established on Staten Island to assist with quarantine activities against cholera, yellow fever, smallpox, and plague. Within months, The Hygienic Laboratory, as it was called, had for the first time in the US, isolated the cholera bacillus. This was the beginning of the National Institutes of Health (NIH), which has since supported life-saving di...

Cross-training’s not just for the gym anymore, people. PricewatershouseCoopers (PWC) just released “New chemistry: Getting the Biopharmaceutical Talent Formula Right,” their report on the education and skills that will be needed for the pharmaceutical jobs of tomorrow. The takeaway? Learn more than just (!) science.

The PWC report predicts that most pharma companies will be revamping their R&D organization models from a pure science orientation to one that leverages partnerships and alliances. This is no surprise. Pharma’s increas...

Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon